1681 Results for "

Ca

" in MedChemExpress (MCE) Product Catalog:
Products (1681)

1681 Results for "Ca" in MCE Product Catalog:

20
20 Cited Publications
Cat. No.: HY-13764
CAS No.: 518-34-3
Purity:  99.90%
Synonyms: NSC-77037; d-Tetrandrine
Tetrandrine (NSC-77037; d-Tetrandrine) is a bis-benzyl-isoquinoline alkaloid, which inhibits voltage-gated Ca 2+ current (ICa) and Ca 2+-activated K + current.
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-15515
CAS No.: 223104-29-8
Purity:  99.95%
Target:  

Na+/Ca2+ Exchanger

Research Areas:  

Cardiovascular Disease

SEA0400 is a novel and selective inhibitor of the Na +-Ca 2+ exchanger (NCX), inhibiting Na +-dependent Ca 2+ uptake in cultured neurons, astrocytes, and microglia with IC50s of from 5 to 33 nM.
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-N1584B
CAS No.: 1217623-74-9
Synonyms: RU-19110 hydrochloride
Halofuginone hydrochloride (RU-19110 hydrochloride), a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM . Halofuginone hydrochloride is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activity . Halofuginone hydrochloride is also a potent pulmonary vasodilator by activating Kv channels and blocking voltage-gated, receptor-operated and store-operated Ca 2+ channels. Halofuginone hydrochloride has anti-malaria, anti-inflammatory, anti-cancer, anti-fibrosis effects .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-101455
CAS No.: 892711-75-0
Purity:  99.89%
Target:  

Calcium Channel

Research Areas:  

Metabolic Disease

CDN1163 is an allosteric sarco/endoplasmic reticulum Ca 2+-ATPase (SERCA) activator that improves Ca 2+ homeostasis. CDN1163 attenuates diabetes and metabolic disorders .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-12542
CAS No.: 7261-97-4
Purity:  ≥98.0%
Synonyms: F 368
Dantrolene is an orally active, non-competitive glutathione reductase inhibitor with a Ki of 111.6 μM and an IC50 of 52.3 μM. Dantrolene is also a calcium channel protein inhibitor. Dantrolene inhibits the release of Ca 2+ from RyR1 and RyR3, which can be beneficial in a variety of pathologies caused by disruptions in calcium homeostasis (e.g., stroke, ischemia/reperfusion injury, and neurodegenerative diseases). Dantrolene offers relief of muscle spasms, malignant hyperthermia, and antitoxic, antipyretic, and anti-inflammatory properties .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-14657
CAS No.: 14663-23-1
Purity:  99.79%
Synonyms: F 440
Dantrolene sodium is an orally active, non-competitive glutathione reductase inhibitor with a Ki of 111.6 μM and an IC50 of 52.3 μM. Dantrolene sodium is also a calcium channel protein inhibitor. Dantrolene sodium inhibits the release of Ca 2+ from RyR1 and RyR3, which can be beneficial in a variety of pathologies caused by disruptions in calcium homeostasis (e.g., stroke, ischemia/reperfusion injury, and neurodegenerative diseases). Dantrolene sodium offers relief of muscle spasms, malignant hyperthermia, and antitoxic, antipyretic, and anti-inflammatory properties .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-12542A
CAS No.: 24868-20-0
Purity:  99.79%
Synonyms: Dantrolene sodium hydrate
Dantrolene sodium hemiheptahydrate is an orally active, non-competitive glutathione reductase inhibitor with a Ki of 111.6 μM and an IC50 of 52.3 μM. Dantrolene sodium hemiheptahydrate is also a calcium channel protein inhibitor. Dantrolene sodium hemiheptahydrate inhibits the release of Ca 2+ from RyR1 and RyR3, which can be beneficial in a variety of pathologies caused by disruptions in calcium homeostasis (e.g., stroke, ischemia/reperfusion injury, and neurodegenerative diseases). Dantrolene sodium hemiheptahydrate offers relief of muscle spasms, malignant hyperthermia, and antitoxic, antipyretic, and anti-inflammatory properties .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-B0246
CAS No.: 298-46-4
Synonyms: CBZ; NSC 169864
Carbamazepine is an orally active pressure-sensitive sodium ion channel blocker with an IC50 of 131 μM. Carbamazepine blocks voltage gated Na +, Ca 2+, and K + channels, and is also a HDAC inhibitor (IC50: 2 μM). Carbamazepine is an anticonvulsant and can be used for research of epilepsy and neuropathic pain .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-B0193A
CAS No.: 19237-84-4
Prazosin hydrochloride is a well-tolerated, CNS-active α1-adrenergic receptor antagonist for the research of high blood pressure and alcohol use disorders . Prazosin hydrochloride potently inhibits Norepinephrine (NE)-stimulated 45Ca efflux with an IC50 of 0.15 nM .Prazosin hydrochloride inhibits organic cation transporters OCT-1 and OCT-3 with IC50s of 1.8, and 13 μM, respectively .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-70037
CAS No.: 226256-56-0
Synonyms: AMG 073
Cinacalcet (AMG 073) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease research.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-70037A
CAS No.: 364782-34-3
Synonyms: AMG-073 hydrochloride
Cinacalcet hydrochloride (AMG-073 hydrochloride) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease treatment.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-126010
CAS No.: 2253744-54-4
Purity:  99.93%
Target:  

Piezo Channel

Research Areas:  

Others

Dooku1 is a reversibly Yoda1 antagonist with IC50 value of 1.3 μM and 1.5 μM for 2 μM Yoda1-induced Ca 2+ entry HEK 293 cells and HUVECs, respectively. Dooku1 can disrupt Yoda1-induced Piezo1 channel activity and inhibit Yoda1-induced relaxation of aorta. Dooku1 can be used for vascular physiology and disease research .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-A0057
CAS No.: 60142-96-3
Target:  

Calcium Channel

Research Areas:  

Neurological Disease Cancer

Gabapentin is a potent, orally active P/Q type Ca 2+ channel blocker. Gabapentin inhibits neuronal Ca 2+ influx and reduction of neurotransmitter release. Gabapentin is a GABA analog that can be used to relieve neuropathic pain .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-A0057A
CAS No.: 60142-95-2
Target:  

Calcium Channel

Research Areas:  

Neurological Disease Cancer

Gabapentin hydrochloride is a potent, orally active P/Q type Ca 2+ channel blocker. Gabapentin hydrochloride inhibits neuronal Ca 2+ influx and reduction of neurotransmitter release. Gabapentin hydrochloride is a GABA analog that can be used to relieve neuropathic pain .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-B0782
CAS No.: 59-66-5
Acetazolamide is a carbonic anhydrase (CA) IX inhibitor with an IC50 of 30 nM for hCA IX. Acetazolamide has diuretic, antihypertensive and anti-gonococcal activities .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-B0782A
CAS No.: 1424-27-7
Acetazolamide sodium is a carbonic anhydrase (CA) IX inhibitor with an IC50 of 30 nM for hCA IX. Acetazolamide sodium has diuretic, antihypertensive and anti-gonococcal activities .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-15553A
CAS No.: 116666-63-8
Synonyms: Ro 40-5967 dihydrochloride
Target:  

Calcium Channel

Research Areas:  

Cardiovascular Disease Cancer

Mibefradil dihydrochloride (Ro 40-5967 dihydrochloride) is a calcium channel blocker with moderate selectivity for T-type Ca 2+ channels (IC50s of 2.7 μM and 18.6 μM for T-type and L-type currents, respectively) .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-123071
CAS No.: 1206604-29-6
Purity:  99.24%
Target:  

Wnt

Research Areas:  

Cancer

Box5 is a potent Wnt5a antagonist. Box5 inhibits Wnt5a signaling and inhibits Wnt5a-mediated Ca 2+ release. Box5 inhibits cell migration. Box5 has the potential for the research of melanoma .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-123071A
Purity:  99.24%
Target:  

Wnt

Research Areas:  

Cancer

Box5 TFA is a potent Wnt5a antagonist. Box5 TFA inhibits Wnt5a signaling and inhibits Wnt5a-mediated Ca 2+ release. Box5 TFA inhibits cell migration. Box5 TFA has the potential for the research of melanoma .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-19940
CAS No.: 1450824-22-2
Synonyms: TD139; GB0139
Olitigaltin (TD139) is a high-affinity Galectin-3 inhibitor with a Kd value of 14 nM. Olitigaltin inhibits the activity of the AKT/β-catenin pathway, induces Apoptosis, and downregulates SREBP1 expression. Olitigaltin enhances the phosphorylation level of ERK. Olitigaltin alleviates bleomycin (HY-17565A)-induced advanced pulmonary fibrosis in mice. Olitigaltin delays the onset of diabetes, and improves glucose tolerance and serum insulin levels. Olitigaltin alleviates liver injury. Olitigaltin maintains the structure of hippocampal excitatory synapses, restores γ-wave power in the hippocampal CA1 region, inhibits hippocampal neuroinflammation, and improves cognitive function in neuroinflammation models. Olitigaltin can be used in research related to thyroid cancer, idiopathic pulmonary fibrosis, type 1 diabetes, hepatitis, and cognitive dysfunction induced by neuroinflammation .
loading...
    loading...